234 related articles for article (PubMed ID: 25423931)
1. [New Developments in CKD-MBD. Strategies for the management of predilalysis CKD-MBD].
Ando R
Clin Calcium; 2014 Dec; 24(12):1845-51. PubMed ID: 25423931
[TBL] [Abstract][Full Text] [Related]
2. [New Developments in CKD-MBD. How to "Thinking Global! Acting Local" for treating CKD-MBD].
Tsukamoto Y
Clin Calcium; 2014 Dec; 24(12):1757-61. PubMed ID: 25423919
[TBL] [Abstract][Full Text] [Related]
3. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
4. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
Molony DA; Stephens BW
Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
[TBL] [Abstract][Full Text] [Related]
5. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
[TBL] [Abstract][Full Text] [Related]
6. [New Developments in CKD-MBD. Cell Biology of parathyroid in CKD].
Kakuta T; Sawada K
Clin Calcium; 2014 Dec; 24(12):1801-8. PubMed ID: 25423925
[TBL] [Abstract][Full Text] [Related]
7. Osteo-renal regulation of systemic phosphate metabolism.
Razzaque MS
IUBMB Life; 2011 Apr; 63(4):240-7. PubMed ID: 21438115
[TBL] [Abstract][Full Text] [Related]
8. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
[TBL] [Abstract][Full Text] [Related]
9. The future of phosphate binders: a perspective on novel therapeutics.
Cernaro V; Santoro D; Lucisano S; Nicocia G; Lacquaniti A; Buemi M
Expert Opin Investig Drugs; 2014 Nov; 23(11):1459-63. PubMed ID: 25243756
[TBL] [Abstract][Full Text] [Related]
10. [Chronic kidney disease and nutrition].
Yoshida T; Kumagai H
Clin Calcium; 2016 Mar; 26(3):369-74. PubMed ID: 26923973
[TBL] [Abstract][Full Text] [Related]
11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
12. [New Developments in CKD-MBD. Development and progression of CKD-MBD in predialysis period -when and how?].
Komaba H
Clin Calcium; 2014 Dec; 24(12):1771-8. PubMed ID: 25423921
[TBL] [Abstract][Full Text] [Related]
13. Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate.
Cozzolino M; Bruschetta E; Cusi D; Montanari E; Giovenzana ME; Galassi A
Expert Opin Pharmacother; 2012 Nov; 13(16):2337-53. PubMed ID: 23033914
[TBL] [Abstract][Full Text] [Related]
14. Development of a quantitative systems pharmacology model of chronic kidney disease: metabolic bone disorder.
Gaweda AE; McBride DE; Lederer ED; Brier ME
Am J Physiol Renal Physiol; 2021 Feb; 320(2):F203-F211. PubMed ID: 33308018
[TBL] [Abstract][Full Text] [Related]
15. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
Omata M; Fukagawa M; Kakuta T
Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
[TBL] [Abstract][Full Text] [Related]
16. Phosphorus and other aspects of CKD-MBD in the conservative management of chronic kidney disease.
Shah A
Panminerva Med; 2017 Jun; 59(2):124-132. PubMed ID: 28290186
[TBL] [Abstract][Full Text] [Related]
17. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
[TBL] [Abstract][Full Text] [Related]
18. Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?
Evenepoel P; Rodriguez M; Ketteler M
Semin Nephrol; 2014 Mar; 34(2):151-63. PubMed ID: 24780470
[TBL] [Abstract][Full Text] [Related]
19. [New Developments in CKD-MBD. New aspects in phosphate binders].
Yokoyama K
Clin Calcium; 2014 Dec; 24(12):1815-23. PubMed ID: 25423927
[TBL] [Abstract][Full Text] [Related]
20. CKD-MBD: impact on management of kidney disease.
Ogata H; Koiwa F; Kinugasa E; Akizawa T
Clin Exp Nephrol; 2007 Dec; 11(4):261-268. PubMed ID: 18085385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]